Upon this findings on HIV resistance, CCR5 blockers or antagonists started to be tested against Acquired Immune Deficiency Syndrome (AIDS) and currently the CCR5 antagonist Maraviroc is clinically used (54). This evidence concerns the gene CCR5 and AIDS.